Green Biologics stock price, funding rounds, valuation and financials

Green Biologics has raised $84.20 m in total funding. Green Biologics annual revenue was £1.51 m in FY 2017

£1.5 M

Green Biologics Revenue FY, 2017
Green Biologics Gross profit (FY, 2017)-8.6 M
Green Biologics Gross profit margin (FY, 2017), %(568.7%)
Green Biologics Net income (FY, 2017)-17.8 M
Green Biologics EBIT (FY, 2017)-17.6 M
Green Biologics Cash, 31-Dec-20174.2 M

Green Biologics Revenue

Green Biologics revenue was £1.51 m in FY, 2017

Embed Graph

Green Biologics Funding

Summary Metrics

Founding Date

2003

Green Biologics total Funding

$84.2 m

Green Biologics latest funding size

$42 m

Time since last funding

6 years ago

Green Biologics investors

Green Biologics's latest funding round in January 2015 was reported to be $42 m. In total, Green Biologics has raised $84.2 m

Green Biologics Capital Raised

Embed Graph

Green Biologics Income Statement

Annual

GBPFY, 2007FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

39.1k1.6m27.8m6.6m1.5m

Revenue growth, %

1829%

Cost of goods sold

22.4k1.4m26.3m10.4m10.1m

Gross profit

16.7k140.7k1.4m(3.8m)(8.6m)

Gross profit Margin, %

43%9%5%(57%)(569%)

Operating expense total

669.6k7.7m11.3m10.5m9.0m

EBITDA

(626.9k)(7.2m)(7.8m)

EBITDA margin, %

(1603%)(26%)(117%)

EBIT

(652.8k)(7.6m)(9.9m)(14.2m)(17.6m)

EBIT margin, %

(1669%)(488%)(36%)(214%)(1167%)

Pre tax profit

(641.9k)(7.6m)(13.0m)(13.9m)(17.9m)

Income tax expense

52.3k231.1k342.7k287.9k109.1k

Net Income

(589.5k)(7.4m)(12.6m)(13.6m)(17.8m)

Green Biologics Balance Sheet

Annual

GBPFY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

11.0k8.5k53.1k572.4k147.1k784.2k2.5m1.0m1.2m10.2m49.4m34.8m2.2m4.2m

Accounts Receivable

221.6k235.9k367.5k444.8k475.9k552.0k879.5k402.7k102.8k274.0k

Inventories

2.0k2.0k1.1m906.7k1.1m1.2m

Current Assets

1.013.8k11.3k63.7k655.5k368.6k1.0m2.8m1.5m1.7m10.7m52.4m37.5m4.7m7.1m

PP&E

4.5k7.4k17.6k158.2k275.6k210.9k175.1k107.4k3.5m159.0k17.0m29.2m63.0m62.6m

Goodwill

253.5k253.5k

Total Assets

1.018.3k18.7k81.3k813.7k644.2k1.2m3.0m4.1m5.2m16.7m69.7m67.0m71.8m70.0m

Accounts Payable

75.1k351.3k1.0m482.2k480.8k306.1k358.1k853.1k5.3m1.5m612.4k

Current Liabilities

17.3k10.0k21.7k130.5k351.3k1.0m482.2k480.8k306.1k358.1k4.4m10.9m13.0m5.3m

Non-Current Liabilities

21.6m18.2m29.0m55.3m

Total Liabilities

17.3k10.0k21.7k130.5k351.3k1.0m482.2k480.8k306.1k358.1k26.0m29.1m41.9m60.6m

Common Stock

1.076.086.0100.0232.0269.0332.0562.0713.0909.01.7k4.0k4.4k3.9k3.9k

Retained Earnings

(10.1m)(25.2m)(34.8m)(48.1m)(67.7m)

Total Equity

1.01.0k8.7k59.6k683.2k292.9k212.0k2.5m3.6m4.9m16.3m43.7m37.9m29.9m9.4m

Financial Leverage

1 x18 x2.2 x1.4 x1.2 x2.2 x5.8 x1.2 x1.1 x1.1 x1 x1.6 x1.8 x2.4 x7.5 x

Green Biologics Cash Flow

Annual

GBPFY, 2007FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(589.5k)(7.4m)(12.6m)(13.6m)(17.8m)

Cash From Operating Activities

(5.2m)(3.4m)(10.5m)(16.4m)

Cash From Financing Activities

55.1m(2.2k)18.6m18.4m

Net Change in Cash

35.7m(18.3m)(27.2m)1.1m

Income Taxes Paid

231.1k370.2k

Green Biologics Ratios

GBPFY, 2003

Financial Leverage

1 x